EUVIMEDEUVIMED entdecken
Crossref

Stem cells in managing glaucoma

Francesco Cappellani, Matteo Capobianco, Federico Visalli, Alessandro Avitabile, Giuseppe Gagliano, Simonetta Gaia Nicolosi, Marieme Khouyyi, Fabiana D’Esposito, Caterina Gagliano, Marco Zeppieri

World Journal of Stem Cells · 26.06.2026 · 18 (6)

DOI: 10.4252/wjsc.120083 ↗

Kurz gefasst

Fachartikel in der Zeitschrift World Journal of Stem Cells, online erschienen am 26.06.2026. Verfasst von Francesco Cappellani und 9 weiteren Autor:innen. Die Arbeit nennt 53 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glaucoma is a chronic neurodegenerative condition of the visual system characterized by the progressive death of retinal ganglion cells (RGCs), resulting in irreversible vision impairment. Although current therapies effectively lower intraocular pressure, they do not directly target the fundamental neuronal loss that leads to prolonged vision deterioration. Stem cell-based therapies have emerged as a promising regenerative approach, aiming to preserve neural tissue, alter pathological microenvironments, and potentially restore impaired visual circuitry. Recent preclinical and early translational studies suggest that embryonic, induced pluripotent, and mesenchymal stem cells can enhance the lifespan of RGCs via trophic support, immunomodulation, and modulation of glial responses. Progress in pluripotent stem cell differentiation has facilitated the creation of retinal progenitors and RGC-like cells that can partially integrate into experimental animals. Nonetheless, significant obstacles - such as axonal regeneration, functional connection, immunological responses, and long-term safety - must be addressed. Ongoing advancements in stem cell engineering, biomaterials, and delivery methods indicate that regenerative therapies may ultimately augment or surpass pressure-lowering strategies, creating new opportunities for disease modification and visual restoration in glaucoma.

Zitieren

APA

Cappellani, F., Capobianco, M., Visalli, F., Avitabile, A., Gagliano, G., Nicolosi, S. G., Khouyyi, M., D’Esposito, F., Gagliano, C., & Zeppieri, M. (2026). Stem cells in managing glaucoma. World Journal of Stem Cells, 18(6). https://doi.org/10.4252/wjsc.120083

Vancouver

Cappellani F, Capobianco M, Visalli F, Avitabile A, Gagliano G, Nicolosi SG, et al. Stem cells in managing glaucoma. World Journal of Stem Cells. 2026;18(6). doi:10.4252/wjsc.120083

BibTeX
@article{Cappellani2026,
  author = {Cappellani, Francesco and Capobianco, Matteo and Visalli, Federico and Avitabile, Alessandro and Gagliano, Giuseppe and Nicolosi, Simonetta Gaia and Khouyyi, Marieme and D’Esposito, Fabiana and Gagliano, Caterina and Zeppieri, Marco},
  title = {Stem cells in managing glaucoma},
  journal = {World Journal of Stem Cells},
  year = {2026},
  volume = {18},
  number = {6},
  doi = {10.4252/wjsc.120083}
}
Kostenlos starten →